← Back to Search

Catheter Anterior to Femoral Nerve for Continuous Femoral Nerve Blocks

Phase 4
Waitlist Available
Led By Brian M Ilfeld, M.D., M.S.
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up percentage of baseline muscle strength six hours after infusion initiation
Awards & highlights

Summary

To determine if the way local anesthetic, or numbing medication, is delivered through a tiny tube next to the nerves that go to the thigh affects the strength and sensation in the thigh.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~percentage of baseline muscle strength six hours after infusion initiation
This trial's timeline: 3 weeks for screening, Varies for treatment, and percentage of baseline muscle strength six hours after infusion initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quadriceps femoris muscle strength

Trial Design

2Treatment groups
Active Control
Group I: Catheter Anterior to Femoral NerveActive Control1 Intervention
Each subject will have one lower extremity (Right or Left) randomized to receive a perinural catheter, placed anterior to the femoral nerve, with a continuous infusion of local anesthetic and then the outcomes will be measured.
Group II: Catheter Posterior to Femoral NerveActive Control1 Intervention
Each subject will have the opposite lower extremity (Right or Left) randomized to receive a perinural catheter, placed posterior to the femoral nerve, with a continuous infusion of local anesthetic and then the outcomes will be measured.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,135 Previous Clinical Trials
1,551,225 Total Patients Enrolled
Brian M Ilfeld, M.D., M.S.Principal InvestigatorUniversity of California, San Diego
14 Previous Clinical Trials
1,063 Total Patients Enrolled
~1 spots leftby Aug 2025